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Abstract
Objectives: This study was conducted to assess the management of incidental gallbladder cancer and
indeterminate gallbladder lesions. Its secondary aim referred to the devising of a management pathway
for these patients.
Methods: Patients referred with incidental gallbladder cancer and indeterminate gallbladder lesions
during 2002–2011 were identified from a prospectively maintained database. Collated data included
operative findings, histopathological data and survival outcomes.
Results: The study included a total of 104 patients, 40 of whom had incidental gallbladder cancer
following cholecystectomy. In this group, the index cholecystectomy was considered curative (T-is/T1a
stage) in three patients; 11 patients underwent further resection, and 26 patients were inoperable. One-,
3- and 5-year overall survival rates were 91.1%, 91.0% and 60.7%, respectively, in patients who
underwent re-resection. Of the 64 patients with indeterminate gallbladder lesions, 54 patients underwent
modified radical cholecystectomy. Seven patients were found to have gallbladder cancer. One-, 3- and
5-year overall survival rates were 85.9%, 43.1% and 42.8%, respectively. Five-year overall survival in
patients treated with surgery for gallbladder cancer was 59.9%.
Conclusions: The majority of patients with incidental gallbladder cancer were not amenable to further
potentially curative resection. The radiological suspicion of gallbladder cancer should lead to prompt
referral to a tertiary hepatobiliary unit for further management.
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Introduction
Gallbladder cancer is a rare malignancy in Western populations
and is associated with a poor prognosis,1 mainly as a result of
rapid tumour progression. Patients usually present with meta-
static disease. In patients who are suitable for surgery, extensive
liver resection, with or without portal lymphadenectomy and bile
duct resection, is frequently required for disease eradication, but is
associated with high morbidity and occasional mortality.2
However, the definitive surgical treatment for gallbladder cancer
remains controversial, especially with respect to the extent of
resection in different stages and modes of presentation. Some
centres would consider radical surgery for advanced T3 gallblad-
der cancer.2,3
In the majority of cases, gallbladder cancers are discovered inci-
dentally following cholecystectomy.4,5 Using the American Joint
Committee on Cancer (AJCC) staging system, simple cholecystec-
tomy alone is considered definitive treatment if the histological
T-stage is T in situ or T1a, and provided there is no biliary spillage
during surgery.6 Some centres have reported reduced disease
recurrence rates and better survival outcomes with resection of
the liver bed following the incidental diagnosis of gallbladder
cancer post-cholecystectomy.2,7,8 The recommended treatment for
suspected but resectable gallbladder cancer on imaging is hepatic
resection with or without lymphadenectomy and bile duct resec-
tion.2,9 However, the management strategy is unclear when cross-
sectional imaging is indeterminate. There is a risk that either a
patient with gallbladder cancer will be undertreated with simple
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cholecystectomy, which may potentially affect his or her longterm
survival, or that a patient with a benign inflammatory process may
be overtreated by liver resection with portal lymphadenectomy,
in which there is significant increase in risk for postoperative
complications.
The aim of this study was to assess the management of inciden-
tal gallbladder cancer found following simple cholecystectomy
and of gallbladder lesions that are indeterminate on imaging. The
secondary aim referred to the devising of a management pathway
for patients in whom possible gallbladder cancer is suspected on
initial diagnostic imaging.
Materials and methods
Patients in whom an initial diagnostic scan raised radiological
suspicion and patients with histologically proven gallbladder
cancer following cholecystectomy were identified from a prospec-
tively maintained hepatobiliary database. All patients had been
referred to the study centre during the 9.5-year period from
January 2002 to August 2011. Ethics approval for this study was
obtained from the University Hospital Aintree.
There were two patterns of referral to this tertiary centre: (i)
patients with incidental gallbladder cancer after cholecystectomy
carried out at a non-tertiary centre were referred for further
management, and (ii) patients with radiologically indeterminate
gallbladder lesions were referred for modified radical cholecystec-
tomy. A radiologically indeterminate gallbladder lesion was
defined as focal or diffuse thickening of the gallbladder wall, a
mass in the gallbladder fossa or an intraluminal mass, with or
without associated findings of cholelithiasis, biliary duct dilata-
tion, invasion of the adjacent structures, distant metastases other
than those of the liver, and porcelain gallbladder.10,11 Patients were
excluded if preoperative imaging clearly suggested gallbladder
cancer, N2 stage or M1 stage disease, and if their follow-up after
surgery amounted to <12 months.
Collated data included patient demographics, laboratory analy-
ses, type of surgical resection, histopathology analysis and clinical
outcome. Preoperative radiological assessment included abdomi-
nal ultrasonography (US), computed tomography (CT) scans of
the thorax, abdomen and pelvis, and magnetic resonance imaging
(MRI) of the liver (from 2008).
All patients were discussed in a specialist multidisciplinary
team (MDT) meeting that included hepatobiliary surgeons, and a
hepatologist,medical oncologist, radiologist and pathologist prior
to surgery or systemic or palliative management.
Revision radical cholecystectomy was offered to patients with
incidental gallbladder cancer after cholecystectomy, and without
distant metastases on staging CT. T-stages of T-is or T1a disease
were considered as curative following the initial cholecystectomy
and no further radical intervention was provided.6 In patients
with indeterminate gallbladder lesions on imaging, modified
radical cholecystectomy was offered. No preoperative histological
diagnosis is obtained in this group of patients.
Surgical data
The operative data from the initial cholecystectomy in the inci-
dental gallbladder cancer group were obtained from referral
centres and surgical procedures were graded as simple or difficult.
A procedure was defined as ‘difficult’ either according to clear
documentation in the operation notes and/or because a
laparoscopic procedure had required to be converted to an open
approach. Other data collated included: bile spillage during chol-
ecystectomy; surgical incision (laparoscopic versus open); type of
surgery (simple versus resection of the gallbladder bed); other
organ involvement, and intraoperative tumour status.
Modified radical cholecystectomy was performed using either a
laparoscopic or an open approach. The laparoscopic approach
involved the placement of four ports as per standard laparoscopic
cholecystectomy. Following initial assessment, a decision was
made to proceed either laparoscopically or to convert to an open
procedure based on whether the critical view of safety could be
dissected.12 Following dissection, the proximal cystic duct was sent
for frozen section examination. The gallbladder was removed en
bloc with a 1–2-cm cuff of segment IVb/V of the liver using a
Harmonic scalpel (Ethicon Endo-Surgery, Inc, Cincinnati, OH,
USA). If the frozen sections were suspicious or positive for gall-
bladder cancer, the operation was converted to open in order
to facilitate a more extensive lymphadenectomy and bile duct
excision with biliary reconstruction using Roux-en-Y hepatico-
jejunostomy.13 All gallbladders harvested using the laparoscopic
approach were routinely retrieved using a specimen retrieval bag.
Trocar sites were not routinely excised in this cohort. Open pro-
cedures were performed in exactly the same manner.
The length of hospital stay, postoperative complications and
30-day mortality were recorded.
Histopathology analysis
Histological tumour–node–metastasis (TNM) staging, tumour
status at the cystic duct and resection margins were recorded.
Microvascular involvement was also noted. As the majority of
patients in the incidental gallbladder cancer group were referred
from other hospitals, highly accurate histological T-staging was
not always available for all patients for data analysis. However,
provided that there was an indication for re-resection after the
confirmation of incidental gallbladder cancer, all histological sec-
tions of the gallbladder were reviewed at the study centre.
Follow-up protocol
Patients were followed up in a specialist hepatobiliary clinic. Fol-
lowing initial postoperative review at 1 month, all patients were
examined in the outpatient clinic at 3, 6, 12, 18 and 24months and
annually thereafter. All patients in this study had a minimum
follow-up of 1 year following surgery. Surveillance imaging
included CT scans of the thorax, abdomen and pelvis. Patients
underwent 6-monthly CT during the first 2 years postoperatively
and annual CT scans thereafter.
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Overall and disease-free survival data were recorded. Disease-
free survival was defined as the time from primary resection to the
first documented recurrence of disease on imaging. Overall sur-
vival was defined as the time interval between the date of primary
resection and the date of death or most recent date of follow-up if
the patient was still alive.
Statistical analysis
Categorical data were presented as frequencies and proportions
(%) and were analysed using Pearson’s chi-squared test or Fisher’s
exact test.Medians (range) were used to describe continuous data.
The Kaplan–Meier method was used to assess actuarial survival
and disease-free survival. Univariate analysis was performed to
assess for significant differences in clinicopathological character-
istics that influenced disease recurrence and survival following
resection. A multivariate analysis was performed using Cox
regression (stepwise forward model) for variables significant on
univariate analysis. All statistical analyses were performed using
SigmaPlot forWindowsVersion 12 (Systat Software, Inc., Chicago,
IL, USA) and statistical significance was set at the 5% level.
Results
A total of 104 patients were identified for the study period,
40 of whom had incidental gallbladder cancer following
cholecystectomy.
Incidental gallbladder cancer
Of the 40 patients with incidental gallbladder cancer following
cholecystectomy, 21 (52.5%) patients were not offered further
surgery (Fig. 1, Table 1). In three patients, the index cholecystec-
tomy was considered curative (T1a stage); in the remaining
18 patients, subsequent cross-sectional imaging performed for
staging revealed locally unresectable or metastatic disease. Of
these 18 patients, nine (50.0%) had biliary spillage secondary to
gallbladder perforation during initial cholecystectomy. In addi-
tion, the completeness of cholecystectomy was not recorded in
six patients.
Of the 19 patients with incidental gallbladder cancer who were
offered surgery, eight (42.1%) were found to have metastatic peri-
toneal disease at laparotomy, which was confirmed by frozen
section examination. Six of the eight (75.0%) patients had biliary
spillage during the index cholecystectomy. The remaining 11
patients underwent open resection of the gallbladder bed (seg-
ments IVb/V). The overall morbidity rate was 15.8% (n = 3). Two
patients suffered Grade II complications (nosocomial pneumonia
and supraventricular tachycardia), and one suffered a Grade III
complication of biliary leak without further intervention.14 One of
these 11 patients, who had biliary spillage during initial cholecys-
tectomy, was subsequently found to have recurrent disease within
1 year after re-resection. Records of initial cholecystectomy status
were not available in 10 patients.
Rates of 1-, 3- and 5-year overall survival in patients submitted
to gallbladder bed re-resection were 91.1%, 91.0% and 60.7%,
respectively. By contrast, patients found to be unresectable on
cross-sectional imaging or at laparotomy had a median survival of
8 months following referral. One patient had disease recurrence at
33 months after hepatic resection following the finding of an
incidental T1a gallbladder cancer at the index cholecystectomy.
Indeterminate/suspicious gallbladder cancer
Of the 64 patients with indeterminate gallbladder lesions, 54
patients underwent modified radical cholecystectomy on an
intention-to-treat basis (open surgery, n = 38; laparoscopic
Patients discussed
at MDT
(n = 104) 
Patients with indeterminate or
suspicious gallbladder cancer
(n = 64) 
Observe and repeat
imaging (n = 10)
Radical cholecystectomy
(n = 54)
Patients with incidental
gallbladder cancer
(n = 40)
Offered surgery
(n = 19) 
Not offered surgery
(n = 21)
Cholecystectomy–
definitive procedure
(n = 3) 
Metastatic disease
on imaging
(n = 18)
Radical
cholecystectomy
(n = 11) 
Metastatic disease
at laparotomy
(n = 8)
Gallbladder
cancer
(n = 7)
Chronic
inflammation
(n = 47)
Figure 1 Outcomes in patients with incidental gallbladder cancer and patients with indeterminate or suspicious gallbladder cancer. MDT,
multidisciplinary team
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surgery, n = 7; laparoscopic converted to open surgery, n = 9).
Seven of these 54 patients were found to have gallbladder cancer
and 47 patients had severe chronic inflammation on histo-
pathological analysis (Table 2). In addition to radical cholecystec-
tomy, en bloc resections of the colon or duodenum (n = 4) and
common bile duct (n = 2) were performed. Among those requir-
ing multiple visceral resections, three of four patients had a his-
tological diagnosis of gallbladder cancer.
Table 1 Demographic, operative and histopathological data for patients with incidental gallbladder cancer (n = 40)
Demographic, clinical and pathological factors Operable patients
(n = 14)a
n (%)
Inoperable patients
(n = 26)b
n (%)
P-value
Demographic factors
Age ≥ 65 years 5 (35.7%) 15 (57.7%) 0.320
Male gender 3 (21.4%) 8 (30.8%) 0.715
Surgical factors
Gallbladder perforationc 1 (9.1%) 8 (57.1%) 0.033
Histopathological factor
Tumour–node–metastasis staging 0.037
pT1a 3 (21.4%) 0
pT1b 2 (14.3%) 4 (15.4%)
pT2 8 (57.1%) 5 (19.2%)
pT3 0 4 (15.4%)
pT4 1 (7.1%) 7 (26.9%)
Resection margin (R0 ≥ 1 mm) 14 (100%) NA –
aThe operable group consists of patients who were sufficiently treated by cholecystectomy (n = 3) and subsequent hepatic resection (n = 11).
bHistology details of six patients in the inoperable group were not available.
cInformation was unavailable for one patient in the operable group and 12 patients in the inoperable group.
P-values in bold indicate statistically significant differences (P < 0.05).
NA, not applicable.
Table 2 Demographic, operative and histopathological data for patients with suspicious gallbladder lesions (n = 64)a
Demographic, clinical and pathological factors Patients with malignant disease
(n = 7)
n (%)
Patients with benign disease
(n = 47)a
n (%)
P-value
Demographic factors
Age ≥ 65 years 4 (57.1%) 17 (38.6%) 0.411
Male gender 5 (71.4%) 17 (38.6%) 0.107
Surgery
Additional procedure 3 (42.9%) 4 (9.1%) 0.039
Histopathological factor
Tumour–node–metastasis staging –
pT1a 0 0
pT1b 0 0
pT2 3 (42.9%) 0
pT3 3 (42.9%) 0
pT4 1 (14.3%) 0
Dysplasia NA 2 (4.5%)
Porcelain gallbladder NA 5 (11.4%)
Resection margin (R0 ≥ 1 mm) 7 (100) NA –
aThe benign group consists of patients with a histological diagnosis of benign inflammation (n = 47). Patients who underwent cross-sectional imaging
on follow-up were excluded from this analysis (n = 10).
P-values in bold indicate statistically significant differences (P < 0.05).
NA, not applicable.
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The overall morbidity rate was 14.8% (n = 8). Grade I compli-
cations (post-epidural headache and wound infection) were
observed in two patients, Grade II complications (biliary leak and
acute renal failure) were reported in two patients, Grade IIIa com-
plications (duodenal fistula formation, pulmonary embolism and
biliary fistula) were seen in three patients, and Grade IIIb compli-
cations (wound dehiscence and persistent biliary fistula) occurred
in one patient.14 Median survival in patients with gallbladder
malignancy was 18.9 months (range: 13–77 months). Rates of 1-,
3- and 5-year overall survival were 85.9%, 43.1% and 42.8%,
respectively. Two of these seven patients had local recurrence
and one had distant metastases. Rates of 1-, 3- and 5-year disease-
free survival in these patients were 57.2%, 43.0% and 42.8%,
respectively.
The remaining 10 patients underwent a period of observation
and repeat cross-sectional imaging; none developed recurrence
during the follow-up period.
Overall, four of 21 (19.0%) patients with curative resection for
gallbladder cancer had disease recurrence. Five-year overall sur-
vival in these patients was 59.9%. Although 1-, 3- and 5-year
survival appeared to be better in the group undergoing
re-resection for incidental gallbladder cancer than in patients
undergoing modified radical cholecystectomy, the difference
between the groups in survival was not statistically significant
(P = 0.23).
Discussion
Gallbladder cancer remains a difficult malignancy to manage, par-
ticularly in those patients referred to tertiary centres with an inci-
dental histopathological diagnosis of underlying malignancy
following apparently straightforward cholecystectomy. In the
present cohort, the further management of 104 patients was dis-
cussed in MDT meetings following either incidental histology-
proven gallbladder malignancy or suspicious gallbladder cancer
on cross-sectional imaging.Over the last decade, regional policy at
the study centre has required the tertiary referral of all suspicious
or confirmed gallbladder malignancies to the unit’s MDT
meeting. Hence, this study reports a true denominator for the
incidence of incidental gallbladder cancers following cholecystec-
tomy in a general European population. This is a key difference
between the present study and other studies published in the
literature.15–18
With respect to patients in whom incidental gallbladder cancer
was found following cholecystectomy, the proportions of patients
subsequently found to be eligible for further hepatic resection
varied among centres.2,7,19 This difference may reflect referral bias
dependent on the policies of the referring hospital and the respec-
tive tertiary centre. Fong et al.2 and Paolucci et al.20 reported rates
of hepatic resection with curative intent for incidental gallbladder
cancer of 32% and 29%, respectively. By contrast, the present
series observed a resection rate of 25.0% in such patients. The
exact reason for this small difference is unknown, but it may be
explained by the delay in referral from the district general hospital
following cholecystectomy and subsequent histology analysis. In
addition, the majority of published studies were retrospective in
nature and hence did not report the proportion of patients under-
going subsequent futile laparotomy.7
The present series also demonstrated that further potentially
curative surgery could not be offered tomore than half of 50.0% of
the patients found to have incidental gallbladder cancer following
cholecystectomy, and hence indicated the loss of any survival
benefit of resection.21 In patients who proceeded to surgery with
curative intent in this incidental group, curative resection was not
feasible in 42.1% as a result of either locally advanced or peritoneal
disease following the initial cholecystectomy.A possible contribut-
ing factor was biliary spillage secondary to gallbladder perforation.
Fong and co-workers2 compared findings in patients with gall-
bladder cancer diagnosed after cholecystectomy with findings in
those without histological diagnoses and discovered that patients
without previous cholecystectomy had higher T-stage disease and
were therefore less likely to be suitable for curative resection.
These results suggested that initial cholecystectomy was not asso-
ciated with a lower likelihood of definitive curative resection. In
the present cohort, a higher T-stage in the primary resection
group than in the incidental group was similarly observed.
Current 5-year survival data for patients with gallbladder
cancer who undergo radical cholecystectomy or subsequent
hepatic resection range from 21% to 69%.6,22–27 The survival
outcome in the present series is similar to those in these published
reports. In addition, there was no survival difference between
patients who underwent subsequent segment IVb/V re-resection
and those submitted to modified radical cholecystectomy in the
current patient cohort. These results are consistent with the find-
ings of other published studies.17,28,29 Other authors have also
reported a survival benefit in patients with incidental gallbladder
cancer who undergo subsequent hepatic resection compared with
patients who are considered to be unresectable as a result of
disease progression,2,8,17 as was observed in the present study.
Based on the findings above, Fig. 2 summarizes a suggested
management algorithm for both incidental gallbladder cancers
and indeterminate gallbladder lesions. It is recommended that all
patients with suspicious or histologically proven gallbladder
cancer should be referred to a tertiary hepatobiliary centre for
further management within 2 weeks.
Given the present finding that more than 50.0% of patients
would not be offered re-resection following cholecystectomy for
incidental gallbladder cancer, and hence would lose any survival
benefit to be derived from re-resection, it would be reasonable to
recommend that when a non-hepatobiliary surgeon is confronted
by a suspicious gallbladder lesion during laparoscopic cholecys-
tectomy, the procedure should be abandoned and the patient
referred to the respective tertiary hepatobiliary centre for further
management. It may be that the management approach outlined
in Fig. 2 would minimize the number of incidental gallbladder
cancers and optimize potential curative resection rates in this
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group of patients. In line with current national guidelines, which
require a referral to be made within 2 weeks for any suspected
malignancy,30 the 2-week rule was applied in the management
algorithm presented here.
It is challenging to fully differentiate chronic cholecystitis from
a malignant process based on CT imaging.31 This is one of the
reasons why 13% of gallbladder cancer is identified in patients
with indeterminate gallbladder lesions. In addition,most series do
not report the denominators for indeterminate gallbladder lesions
on cross-sectional imaging,2,7,32 but simply use histologically
proven gallbladder cancers as the denominator in the series. It is
therefore impossible to compare actual management strategies for
gallbladder lesions that are indeterminate on imaging among
hepatobiliary centres.
Furthermore, in patients in this cohort with benign chronic
inflammatory disease, surgical intervention is frequently complex
and additional procedures are required. These cases are difficult to
complete laparoscopically and frequently require to be converted
to open procedures, even in the hands of skilled laparoscopic
hepatobiliary surgeons. The degree of inflammation and fibrosis
also increases the risk for bile duct injury in these patients.33
Hence, it is more appropriate to perform such complex biliary
surgery in a tertiary hepatobiliary centre.34
In conclusion, the majority of patients found to have incidental
gallbladder cancer following cholecystectomy are not amenable
to further potentially curative hepatic resection and present
with metastatic disease on cross-sectional imaging post-
cholecystectomy. This significantly lowers their overall survival.
The presence of clinical, radiological and/or intraoperative suspi-
cions of gallbladder cancer should lead to a prompt referral to the
tertiary hepatobiliary unit for further management.
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